Add to ORKGObjective: The objective of this systematic review is to determine whether or not “Does venlafaxine (Effexor) decrease the frequency of hot flashes in women with breast cancer?
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer, this may incr...
Vasomotor flushes are common complaints of women during and after menopause, affecting about 75 perc...
Hot flashes can be a major problem for patients with a history of breast cancer. The precipitation o...
Objective: The objective of this systematic review is to determine whether or not “Does venlafaxine ...
Purpose: Therapies for breast cancer may induce hot flashes that can affect quality of life. We unde...
BackgroundHot flashes are symptoms of vasomotor instability reported in least 50–60% of breast cance...
OBJECTIVE: To obtain practical experience with venlafaxine for hot flushes in breast cancer pa...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
Background Hot flashes can be troublesome, especially when hormonal therapy is contraindicated. Prel...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
OBJECTIVE: The objective of this selective Evidence Based Medicine (EBM) review is to determine whet...
Patient-centered decision making about hot flash treatments often incorporates a balance of efficacy...
Breast cancer is one of the most common malignant diseases. Adjuvant systemic therapies such as chem...
Q: Which nonhormonal treatments are effective for hot flashes? Evidence-based answer: Selective sero...
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer, this may incr...
Vasomotor flushes are common complaints of women during and after menopause, affecting about 75 perc...
Hot flashes can be a major problem for patients with a history of breast cancer. The precipitation o...
Objective: The objective of this systematic review is to determine whether or not “Does venlafaxine ...
Purpose: Therapies for breast cancer may induce hot flashes that can affect quality of life. We unde...
BackgroundHot flashes are symptoms of vasomotor instability reported in least 50–60% of breast cance...
OBJECTIVE: To obtain practical experience with venlafaxine for hot flushes in breast cancer pa...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
Background Hot flashes can be troublesome, especially when hormonal therapy is contraindicated. Prel...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot f...
OBJECTIVE: The objective of this selective Evidence Based Medicine (EBM) review is to determine whet...
Patient-centered decision making about hot flash treatments often incorporates a balance of efficacy...
Breast cancer is one of the most common malignant diseases. Adjuvant systemic therapies such as chem...
Q: Which nonhormonal treatments are effective for hot flashes? Evidence-based answer: Selective sero...
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer, this may incr...
Vasomotor flushes are common complaints of women during and after menopause, affecting about 75 perc...
Hot flashes can be a major problem for patients with a history of breast cancer. The precipitation o...